Société Belge de Transplantation
Belgische Transplantatie Vereniging
Belgian Transplantation Society
Programme
ANNUAL MEETING
Thursday,
March 27th, 2014
(accreditation is applied for)
08h30 REGISTRATION
Scientific Meeting
Two Parallel Sessions
09h00
Free Communication (Session 1)
Room Atlanta
[Chairmen: M. Antoine, P. Evrard]
(7 x 12 min)
Thoracic
. Vandermeulen E, Ricciardi M, Verleden SE, Ruttens D, Van Raemdonck DE, Vos R, Verleden
GM, Vanaudenaerde BM. An immunohistological study to evaluate the role of eosinophils in
chronic lung allograft dysfunction.
. Van Raemdonck D, Neyrinck A, Monbaliu D, Vos R, Van Veer H, De Leyn P, Nevens F, Pirenne
J, Verleden GM. Combined liver & double-lung transplantation with > 11 hours of normothermic
lung preservation.
. Somers J, Ruttens D, Verleden SE, Vandermeulen E, Wauters E, Lambrechts D, Vos R, Verleden GM, Nawrot TS, Vanaudenaerde BM, Van Raemdonck DE. A genetic polymorphism in IL-23
receptor is protective for primary graft dysfunction.
. Thilmany S, Jamart J, Evrard P, Donckier JE. New-onset diabetes mellitus in adult lung transplant recipients.
. Ruttens D, Wauters E, Kiciński M, Verleden SE, Vandermeulen E, Vos R, Van Raemdonck DE,
Nawrot TS, Lambrechts D, Verleden GM, Vanaudenaerde BM. Genetic variation in IL-17RA is
functionally associated with chronic rejection after lung transplantation.
. Voros G, Van Cleemput J, Droogne W, Vanhaecke J, Ciarka A. Correlation of diastolic filling
pressures and echocardiographic parameters of diastolic function after heart transplantation.
. Ciarka A, Van Cleemput J, Droogne W, Voros G, Janssens S, Vanhaecke J. Heart rate after
heart transplantation – an independent predictor of long term survival. Impact of beta blockade
on mortality after heart transplantation.
www.transplant.be
1
09h00
Free Communication (Session 2)
[Chairmen: H. Van Vlierberghe, J-P. Squifflet]
Room Antwerp
(7 x 12 min)
Liver-Intestine / Kidney-Pancreas / Immuno
. Ceulemans LJ, Monbaliu D, Lenaerts K, Hundscheid I, OldeDamink S, De Hertogh G, Vermeire
S, Pirenne J. NOD2 and intestinal transplantation.
. Milicevic M, Weekers L, Grosch S, Bonvoisin C, Bovy C, Meurisse M, Krzesinski JM. What can
be learned from surveillance biopsy in kidney transplantation?
. De Vusser K, Pieters N, Janssen B, Lerut E, Nawroth T, Kuypers D, Naesens M. Intrarenal telomere length and intrarenal arteriosclerosis in pretransplant kidney biopsies.
. Ceulemans LJ, Strypstein S, Verleden S, Ruttens D, Monbaliu D, Vanhaecke J, Meyns B, Verleden G, Van Raemdonck D, Nevens F, Pirenne J. Combined liver/thoracic transplantation: singlecenter experience.
. De Vusser K, Posen A, Kuypers D, Evenepoel P, Claes K, Bammens B, Sprangers B, Meijers B,
Naesens M. The clinical features of thrombotic microangiopathy after kidney transplantation.
. Spilleboudt C, De Wilde V, Vokaer B, Maury S, Hougardy J-M, Rossi M, Flamand V, Le Moine
A. Critical role of heme oxygenase-1 in the control of graft-versus-host disease.
. De Vusser K, Pieters N, Janssen B, Lerut E, Nawroth T, Kuypers D, Naesens M. The discrepancy between the effect of biological aging on baseline and post-transplant histology.
10h30
COFFEE BREAK
11h00
State of the Art Lectures
Room Antwerp
[Chairman: D. Van Raemdonck, R. Lombaerts]
Grinyó JM (Barcelona, Spain).
Current immunosuppressive treatments and the perspectives for the future.
11h40
PhD Thesis Session
Room Antwerp
[Chairman: D. Van Raemdonck, R. Lombaerts]
(2 X 15 min)
. Debbaut C.
Multilevel modelling of hepatic perfusion in support of liver transplantation strategies.
. Verleden S.
Risk factors and phenotypes of chronic rejection after lung transplantation.
www.transplant.be
2
12h10
[Chairman: D. Van Raemdonck, R. Lombaerts]
Room Antwerp
Guidelines related to transplantation
Nagler E. (Methods Support Team, European Renal Best Practice;
Renal Division, Department Internal Medicine, Ghent University Hospital)
ERBP transplant guidelines and the challenge of uniting European Nephrologists
12h30
LUNCH
13h30
BTS-section Transplant Coordinators
Room Antwerp
[Chairman: D. Van Deynse, P. Evrard]
Desschans B. Donor and Transplant Reports 2013.
BTS award for organ donation
14h00
Free Communications (Session 3)
Room Antwerp
[Chairmen: J.L. Bosmans, V. Donckier]
(10 x 12 min)
. Rossi M, Delbauve S, Thierry A, Spilleboudt C, Leo O, Flamand V, Le Moine A, Hougardy JM.
lo
HO-1-dependent CD11b*F4/80 renal cells confer resistance against renal I/R.
. Meurisse N, Fieuws S, Jochmans I, Laleman W, Aerts R, Nevens F, van der Merwe S, Verslype
C, Cassiman D, Van Steenbergen W, Pirenne J, Monbaliu D. Risk factors to develop biliary nonanastomotic strictures, a single center experience.
. Peeters P, Bosmans J-L, Weekers L, Sennesael J, Kuypers D, Broeders N, Van Laecke S,
Wissing M, Vanhoutte K, Abramowicz D. A prospective, randomized, long-term study on graft
function comparing a steroid-free to a calcineurin-inhibitor-free imunosuppressive treatment after
de novo kidney transplantation.
. Cappelle M, Masschlein E, Van Remoortel H, Smets S, Goetschalckx K, Hespel P, Gosselink R,
Jochmans I, Pirenne J, Monbaliu D. Intensive physical exercise after organ transplantation: a retrospective study in selected patients.
. Meurisse N, Fieuws S, Jochmans I, Laleman W, Aerts R, Nevens F, van der Merwe S, Verslype
C, Cassiman D, Van Steenbergen W, Pirenne J, Monbaliu D. Early allograft dysfunction decreases patient survival after liver transplantation.
. Ceulemans LJ, Marquez M, Grant D, Pirenne J. Global trends in intestinal transplantation: the
2013 international intestinal transplant registry report.
. Van Remoortel H, Masschelein E, Troosters T, Hespel P, Gosselink R, Jochmans I, Pirenne J,
Monbaliu D. Effect of an intenstive exercise program on daily physical activity in solid organ
transplant recipients.
www.transplant.be
3
. Hellemans R, Hazzan M, Durand D, Mourad G, Lang Ph, Kessler M, Charpentier B, Touchard G,
Berthoux F, Merville P, Ouali N, Squifflet J-P, Bayle F, Wissing KM, Noël C, Abramowicz D.
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients:
5-year follow-up of a prospective, randomized study.
. Derthoo D, Van Caenegem O, De Pauw M, Nellessen E, Duerinckx N, Ciarka A, Droogné W,
Van Cleemput J, Belmans A, Meyns B, Vanhaecke J. A randomized trial of everolimus initiation
and calcineurin inhibitor elimination in stable heart transplant recipients with impaired renal function.
. Dupriez F, De Pauw L, Van Deynse D, Mourad M, Darius T, Verschuren F. Fourteen years of
experience in uncontrolled organ donation after cardio-circulatory death.
16h00
COFFEE BREAK
16h30
[Chairman: J. Pirenne, J.L. Bosmans]
Room Antwerp
Belgian Update
Donation after circulatory death national protocol
Evrard P.
An anesthetist preconditioning Belgian study: the rationale
Joris J.
General Assembly
17h15






Room Antwerp
Reports of the President, Treasurer and Secretary
Information ESOT Brussels 2015
Election of new members
Election new board members (October 2014 – September 2019)
Vote on Statute modification
Miscellaneous
18h00
CLOSURE
Location: Courtyard Marriott Brussels
Avenue des Olympiades 6 – 1140 Brussels
www.transplant.be
4